WhisperSom Medical Technologies, Inc — SEC Form D Filing

WhisperSom Medical Technologies, Inc filed an SEC Form D on June 17, 2026, reporting $364K raised in Medical Devices.

Form D filing details

Filing
SEC Form D
Filing date
June 17, 2026
Amount reported
$364K
Round stage
Pre-Seed
Industry
Medical Devices
Website
https://whispersom.com/

What the company does

Securities: Equity, Series A-1 Preferred Stock. Exemption: Rule 506(c). Incorporated: DELAWARE

Problem

Sleep apnea, including Obstructive Sleep Apnea (OSA), is a widespread condition linked to severe health issues, and current treatments like CPAP are often discontinued by patients due to discomfort or dissatisfaction.

Solution

WhisperSomâ„¢ is developing a patented, non-invasive medical device that uses personalized precision acoustic neuromodulation to treat both obstructive and central apneic events during sleep, without requiring masks, implants, or electric shocks.

Why now

There's a growing understanding of the severe health and economic costs associated with untreated sleep apnea, coupled with a demand for more comfortable and effective alternatives to existing treatments like CPAP machines.

Verdict

This cleared because it presented a novel, non-invasive mechanism for a known, high-incidence condition, not because it demonstrated clear clinical superiority or a streamlined regulatory path. Investors implicitly bet on the acoustic neuromodulation technology's efficacy proving out in trials and achieving sufficient differentiation from existing solutions like CPAP and oral appliances. Upside was limited by the significant capital and time required for medical device development and FDA approval, which would likely necessitate multiple, larger subsequent rounds before commercialization.

Source: SEC EDGAR Form D filing